About
Innoventric is a pioneer in transcatheter technology for treating tricuspid regurgitation (TR), focusing on a novel cross-caval approach that simplifies procedures for both physicians and patients. The company's flagship device, Trillium™, offers a fast, safe, and effective solution designed to enhance patient outcomes and broaden the scope of treatable TR cases. Innoventric is dedicated to providing care for all TR patients, especially those who have been historically overlooked in traditional treatments. The company leverages innovative engineering to ensure device reliability and ease of use, with procedures completed in under ten minutes without the need for general anesthesia.
Tags
Total Employees
21
Current headcount
Performance
Company Timeline
No timeline data for this period
Score Breakdown
57Traction
51Team
0Visibility
26Profile
60Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Innoventric do?
Innoventric is a pioneer in transcatheter technology for treating tricuspid regurgitation (TR), focusing on a novel cross-caval approach that simplifies procedures for both physicians and patients. The company's flagship device, Trillium™, offers a fast, safe, and effective solution designed to enhance patient outcomes and broaden the scope of treatable TR cases. Innoventric is dedicated to providing care for all TR patients, especially those who have been historically overlooked in traditional…
How much funding has Innoventric raised?
Innoventric has raised a total of $29M in funding. The most recent round on record is Series B.
When was Innoventric founded?
Innoventric was founded in 2016.
What industry does Innoventric operate in?
Innoventric operates in Healthcare, Medical Devices, Cardiology, Innovation, Biotechnology.
How many employees does Innoventric have?
Innoventric has approximately 21 people on record.